Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Youneng Health Technology is a Chinese biotechnology company specialized in the development and commercialization of early cancer screening and diagnostic solutions. Based in Nanjing, the company focuses on molecular diagnostics, particularly utilizing liquid biopsy and DNA methylation markers for the early detection of various malignancies. Their product portfolio includes testing kits for gastric, colorectal, and liver cancers, aiming to provide non-invasive and highly accurate screening options. The company operates within the In Vitro Diagnostics (IVD) sector and collaborates with clinical institutions to integrate its technologies into routine health check-ups and specialized oncology diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Youneng Health Technology.